BLOCKStrain Technology Corp. (TSX: V: DNAX) (OTC: BKKSF), which built the first blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, is providing its genome tracking software to Canadian licensed producer of medical cannabis Harvest One Cannabis (TSX:V: HVT) (OTCQX: HRVOF).
The BLOCKStrain’s cannabis strain authenticity and tracking platform, called the Master Genome Strain and Clone Registration Program, will allow Harvest One to collect and register its cannabis plant DNA and strains.
The platform will be integrated into Harvest One’s sales program. Upon completion of the collection and registration of its strains, an initial 30 products will carry BLOCKStrain’s Seal of Authenticity, guaranteeing their origin and providing quality assurance.
“BLOCKStrain’s technology is intended to enable us to guarantee that our strain origins and content are exactly as labelled, providing medical consumers with a level of certainty they could not expect with similar, unverified products,” Harvest One CEO Grant Froese said in a statement. “This increased level of quality control is in keeping with our mission build a global house of brands, providing lifestyle and wellness health products to consumers and patients in regulated markets.”
Master Genome Strain and Clone Registration Program
Under its Master Genome Strain and Clone Registration Program, BLOCKStrain’s team collects plant data and performs genomic sequencing in plant batches which are then registered in a blockchain-enabled database for intellectual property protection and strain validation.
BLOCKStrain believes all information gathered from the plants, including their molecular and chemical makeup, can be tracked via the program. Going forward, the company expects a quick response barcode specific to each plant batch will be able to reveal, among other things, how a plant was cloned and cultivated, and its cannabinoid content.
Related
